Arteriosclerosis
Not recruitingInvestigating Lepodisiran for Reducing Cardiovascular Events in Adults with Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease or at Risk for a First Cardiovascular Event
Investigating Lepodisiran for Reducing Cardiovascular Events in Adults with Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease or at Risk for a First Cardiovascular Event
- Disease:Arteriosclerosis
- Substances:LY3819469 sodium
Hungary- Participants:18–64 years · 65+ years
- Substances:LY3819469 sodium
- Sponsor:Eli Lilly & Co.



